More articles from Myelodysplastic Syndromes

Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study
Tatiana Raskovalova, Marc G. Berger, Marie-Christine Jacob, Sophie Park, Lydia Campos, Carmen Mariana Aanei, Julie Kasprzak, Bruno Pereira, José Labarère, Jean-Yves Cesbron, Richard Veyrat-Masson

Haematologica Dec 2019, 104 (12) 2382-2390; DOI: 10.3324/haematol.2018.202275
Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma
Seiichiro Katagiri, Hideki Makishima, Kenko Azuma, Yasuhito Nannya, Yuu Saitoh, Seiichiro Yoshizawa, Daigo Akahane, Hiroaki Fujimoto, Yoshikazu Ito, Ravi Velaga, Tomohiro Umezu, Junko H. Ohyashiki, Seishi Ogawa, Kazuma Ohyashiki

Haematologica Nov 2019, haematol.2019.229856; DOI: 10.3324/haematol.2019.229856
Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a grey zone combination of myelodysplastic and myeloproliferative features?
Valentina FI Sangiorgio, Julia T Geyer, Elizabeth Margolskee, Mustafa Al- Kawaaz, Susan Mathew, Wayne Tam, Attilio Orazi

Haematologica Sep 2019, haematol.2019.227686; DOI: 10.3324/haematol.2019.227686
Synergistic effects of PRIMA-1Met (APR-246) and Azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Pierre Ly, Philippe Aubin, Nadia Naoui, Marie-Helene Schlageter, Cecile Bally, Elsa Miekoutima, Rami Rahmé, Jacqueline Lehmann-Che, Lionel Ades, Pierre Fenaux, Bruno Cassinat, Stephane Giraudier

Haematologica Sep 2019, haematol.2019.218453; DOI: 10.3324/haematol.2019.218453
5-Formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively
Daniel Gackowski, Maciej Gawronski, Cassandra Kerr, Tomas Radivoyevitch, Ewelina Zarakowska, Marta Starczak, Abdulkadir Abakir, Alexey Ruzov, Jaroslaw P. Maciejewski, Ryszard Olinski

Haematologica Sep 2019, haematol.2019.224030; DOI: 10.3324/haematol.2019.224030
Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with associated inflammatory state
Sihem Tarfi, Bouchra Badaoui, Nicolas Freynet, Margot Morabito, Jeffie Lafosse, Andréa Toma, Gabriel Etienne, Jean-Baptiste Micol, Ivan Sloma, Pierre Fenaux, Eric Solary, Dorothée Selimoglu-Buet, Orianne Wagner-Ballon, Groupe Francophone des Myelodysplasies (GFM)

Haematologica Aug 2019, haematol.2019.219782; DOI: 10.3324/haematol.2019.219782
Genomics of therapy-related myeloid neoplasms
Teodora Kuzmanovic, Bhumika J. Patel, Srinivasa R. Sanikommu, Yasunobu Nagata, Hassan Awada, Cassandra M. Kerr, Bartlomiej P. Przychodzen, Babal K. Jha, Devendra Hiwase, Deepak Singhal, Anjali S. Advani, Aziz Nazha, Aaron T. Gerds, Hetty E. Carraway, Mikkael A. Sekeres, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Tomas Radivoyevitch

Haematologica Aug 2019, haematol.2019.219352; DOI: 10.3324/haematol.2019.219352
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Marie Sébert, Aline Renneville, Cécile Bally, Pierre Peterlin, Odile Beyne-Rauzy, Laurence Legros, Marie-Pierre Gourin, Laurence Sanhes, Eric Wattel, Emmanuel Gyan, Sophie Park, Aspasia Stamatoullas, Anne Banos, Kamel Laribi, Simone Jueliger, Luke Bevan, Fatiha Chermat, Rosa Sapena, Olivier Nibourel, Cendrine Chaffaut, Sylvie Chevret, Claude Preudhomme, Lionel Adès, Pierre Fenaux

Haematologica Aug 2019, 104 (8) 1565-1571; DOI: 10.3324/haematol.2018.207118
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
Marlijn Hoeks, Ge Yu, Saskia Langemeijer, Simon Crouch, Louise de Swart, Pierre Fenaux, Argiris Symeonidis, Jaroslav Čermák, Eva Hellström-Lindberg, Guillermo Sanz, Reinhard Stauder, Mette Skov Holm, Moshe Mittelman, Krzysztof Mądry, Luca Malcovati, Aurelia Tatic, Antonio Medina Almeida, Ulrich Germing, Aleksandar Savic, Njetočka Gredelj Šimec, Dominic Culligan, Raphael Itzykson, Agnes Guerci-Bresler, Borhane Slama, Arjan van de Loosdrecht, Corine van Marrewijk, Jackie Droste, Nicole Blijlevens, Marian van Kraaij, David Bowen, Theo de Witte, Alex Smith, EUMDS Registry Participants

Haematologica Jul 2019, haematol.2018.212332; DOI: 10.3324/haematol.2018.212332
Thrombomodulin expressing monocytes are associated with low risk features in myelodysplastic syndromes and dampen excessive immune activation
Nathalie van Leeuwen-Kerkhoff, Theresia M. Westers, Pino J. Poddighe, Tanja D. de Gruijl, Shahram Kordasti, Arjan A. van de Loosdrecht

Haematologica Jul 2019, haematol.2019.219303; DOI: 10.3324/haematol.2019.219303

More articles from Myelodysplastic Syndromes

Pages